However, a convincing method to specifically eradicate oncogenic GPCRs and associated pathological signaling networks is provided by the combination of PROTAC technology with the idea of biased GPCR signaling, opening the door for next‐generation cancer treatments. Here, FZD4 is linked to cancer.